Clinical Trials Directory

Trials / Completed

CompletedNCT03213743

Expression Profiling of microRNA Following Administration of Dexmedetomidine

Expression Profiling of microRNA Following Administration of Dexmedetomidine in Patients Undergoing Procedures

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
3 (actual)
Sponsor
First Affiliated Hospital of Kunming Medical University · Academic / Other
Sex
All
Age
40 Years – 70 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to find out the differential expression profiling of microRNA before and after adiministration of dexmedetomidine in patients undergoing procedures, and then investigators will do some in vitro studies to validate the functions of the microRNA.

Detailed description

Background and objective: The use of dexmedetomidine may have benefits on the clinical outcomes of cardiac surgery. MicroRNAs are non-coding RNA sequences that act as regulators of gene expression. Investigators conduct a study to determine the role of microRNAs in cardioprotection mediated by dexmedetomidine. Methods: In this study 3 patients were selected. The blood sample were taken before administration of dexmedetomidine.Investigators infused loading dose of dexmedetomidine for 10 minutes and maintaining dese of dexmedetomidine for 20 minutes.Thirty minutes after the administration, another blood samples were taken and stored in the liquid nitrogen and both the samples were marked. Those sample were analyzed for differentially expressed microRNA with Exiqon miRNA Array.

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidine InjectionInvestigators gave the patients loading dose of dexmedetomidine for 10 minutes and maintaining dose of dexmedetomidine for 20 minutes. Investigators took blood samples before and after the administration of dexmedetomidine.

Timeline

Start date
2017-06-19
Primary completion
2017-06-21
Completion
2017-06-21
First posted
2017-07-11
Last updated
2017-07-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03213743. Inclusion in this directory is not an endorsement.